Background: The global impact of the COVID-19 pandemic has prompted the search for strategies to improve outcomes in affected individuals, including those initially managed in outpatient settings. Thromboembolic events have been reported as a concerning complication.
Objectives: The aim of this study was to evaluate efficacy and safety of primary thromboprophylaxis in outpatients with COVID-19.
Multimorbidity, i.e., the presence of two or more long-term health conditions, is challenging for healthcare systems worldwide.
View Article and Find Full Text PDF